Stability of isoniazid, rifampin and pyrazinamide in suspensions used for the treatment of tuberculosis in children.

Six-month isoniazid-rifampin treatment for pulmonary tuberculosis in children.

Six-months isoniazid-rifampin treatment for pulmonary tuberculosis in children.

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.

HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients.

Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.

Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines.

U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.

Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.

Simplified microarray system for simultaneously detecting rifampin, isoniazid, ethambutol, and streptomycin resistance markers in Mycobacterium tuberculosis.

Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine.

Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment.

Pyrazinamide in the chemoprophylaxis of tuberculosis.

rifampin drug delivery and osteoarticular tuberculosis therapy.

Rapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array.

British Medical Research Council.

Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis.

Blood levels of isoniazid in Indian children with tuberculosis.

Rapid oral desensitization to isoniazid and rifampin.

Incorporation of pyrazinamide into community-wide treatment of tuberculosis.

Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.

The pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus).

Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA.

The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide.

Efficacy of mupirocin and rifampin used with standard treatment in the management of acne vulgaris.

Suggest Documents

Six-month isoniazid-rifampin treatment for pulmonary tuberculosis in children.

Six-months isoniazid-rifampin treatment for pulmonary tuberculosis in children.

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.

HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients.

Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.

Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines.

U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.

Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.

Simplified microarray system for simultaneously detecting rifampin, isoniazid, ethambutol, and streptomycin resistance markers in Mycobacterium tuberculosis.

Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine.

Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment.

Pyrazinamide in the chemoprophylaxis of tuberculosis.

rifampin drug delivery and osteoarticular tuberculosis therapy.

Rapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array.

British Medical Research Council.

Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis.

Blood levels of isoniazid in Indian children with tuberculosis.

Rapid oral desensitization to isoniazid and rifampin.

Incorporation of pyrazinamide into community-wide treatment of tuberculosis.

Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.

The pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus).

Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA.

The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide.

Efficacy of mupirocin and rifampin used with standard treatment in the management of acne vulgaris.

Stability of isoniazid, rifampin and pyrazinamide in suspensions used for the treatment of tuberculosis in children.

Recommend Documents

Follow Us